Track 20: Ovarian Cancer – Advancing Innovation in Gynecologic Oncology at the 13th International Cancer and Medical Oncology Conference and Exhibition
Ovarian cancer remains one of the most challenging gynecologic malignancies worldwide due to its often late diagnosis, complex biology, and evolving therapeutic landscape. Track 20: Ovarian Cancer at the 13th International Cancer and Medical Oncology Conference and Exhibition, scheduled for February 1–2, 2027, at Novotel Al Barsha, Dubai, UAE , provides a dedicated scientific platform for oncologists, gynecologic oncologists, researchers, pathologists, molecular biologists, clinicians, and healthcare professionals to discuss the latest advancements in ovarian cancer prevention, diagnosis, treatment, survivorship, and translational research. About Track 20: Ovarian Cancer Track 20 focuses on comprehensive scientific and clinical discussions surrounding ovarian cancer, one of the leading causes of cancer-related mortality among women globally. The track aims to address key issues in ovarian cancer biology, screening challenges, biomarkers, molecular pathways, genetic predisposition, pre...